SLXN Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline QURE Q1 2026 Earnings Narrowed Loss Beats Estimates as Gene Therapy Pipeline Steadies Trinity Capital Inc TRIN Q1 2026 Earnings EPS Surpasses Estimates Stock Rises DSGR Q1 2026 Earnings EPS Beats Estimates Stock Edges Lower CRESY Q1 2026 Earnings Strong EPS Performance Amidst Challenging Macro Environment YORW Q1 2026 Earnings EPS Surpasses Estimates Stock Edges Higher Unicycive Therapeutics UNCY Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development NVVE Q2 2025 Earnings Wide Loss Reported Amidst Operational Challenges Stock Gains 69 RDVT Q1 2026 Earnings EPS Beats Estimates by 4093 Stock Rises 217 Werewolf Therapeutics HOWL Q1 2026 Earnings NarrowerthanExpected Loss Highlights Operational Discipline JXN Q1 2026 Earnings EPS Misses Estimates Amid Market Uncertainty Mesa Laboratories Inc MLAB Q1 2026 Earnings Stellar EPS Surprise of 130 Drives Optimism Amidst Quiet Revenue Period